AVITA MEDICAL INC (RCEL) Stock Balance Sheet
NASDAQ:RCEL - Nasdaq - US05380C1027 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 14.87M | N/A | 22.12M | 18.20M | 110.70M | |||
| Marketable Securities | 10.95M | N/A | 66.94M | 61.20M | 29.60M | |||
| Receivables | 12.04M | 12.00M | 7.94M | 5.00M | 7.90M | |||
| Inventories | 8.39M | 7.27M | 5.60M | 2.10M | 1.60M | |||
| Other Current Assets | 1.71M | 2.00M | 1.42M | 1.00M | 1.10M | |||
| Total Current Assets | 47.97M | 57.00M | 104.00M | 87.50M | 121.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 13.25M | 14.00M | 4.32M | 2.10M | 2.90M | |||
| Investments And Advances | N/A | N/A | N/A | 6.90M | 19.70M | |||
| Intangibles | 5.45M | 5.57M | 490.00K | 500.00K | 500.00K | |||
| Other Non-Current Assets | 2.89M | 3.55M | 2.83M | 1.40M | 800.00K | |||
| Total Non-Current Assets | 21.59M | 23.00M | 8.00M | 10.80M | 4.20M | |||
| TOTAL ASSETS | 69.56M | 80.00M | 112.00M | 98.30M | 125.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 8.35M | 11.00M | 8.87M | 7.20M | 4.00M | |||
| Accounts Payable | 8.68M | N/A | 3.79M | 3.00M | 3.10M | |||
| Other Current Liabilities | 5.93M | 2.51M | 540.00K | 500.00K | 200.00K | |||
| Total Current Liabilities | 22.96M | 20.00M | 13.00M | 10.70M | 7.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 41.46M | 42.00M | 40.00M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 9.71M | 13.00M | 9.57M | 2.80M | 2.50M | |||
| Total Non-Current Liabilities | 51.17M | 55.00M | 50.00M | 2.80M | 2.40M | |||
| TOTAL LIABILITIES | 74.13M | 75.00M | 63.00M | 13.50M | 9.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -373.67M | -360.00M | -298.00M | -262.60M | -221.50M | |||
| Additional Paid In Capital | 370.82M | 368.00M | 350.00M | 339.80M | 328.90M | |||
| Common Shares | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.72M | -3.26M | -3.02M | 7.50M | 8.30M | |||
| Shares Outstanding | 26.43M | 26.00M | 26.00M | 25.20M | 24.90M | |||
| Tangible Book Value per Share | -0.38 | -0.04 | 1.87 | 3.34 | 4.63 | |||
| Total Shareholders' Equity | -4.57M | 4.50M | 49.00M | 84.70M | 115.70M | |||
| TOTAL LIABILITIES AND EQUITY | 69.56M | 80.00M | 112.00M | 98.30M | 125.50M | |||
| Statistics | ||||||||
| Debt/Equity | -9.07 | 9.33 | 0.82 | N/A | N/A | |||
| Current Ratio | 2.09 | 2.85 | 8.00 | 8.18 | 16.39 | |||
| Return On Assets (ROA) | -82.01% | -77.31% | -31.59% | -27.13% | -21.18% | |||
| Return On Equity (ROE) | N/A | -1374.33% | -72.21% | -31.49% | -22.97% | |||
All data in USD , ROIC based on taxRate of 0.21